Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2019-03-19 Director's Dealing
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Otrzymanie zawiadomienia od osoby pełniącej obowiązki zarządcze - Content (PL)
Director's Dealing Classification · 95% confidence The document text is very short (442 characters) and explicitly states that a notification ('zawiadomienie') regarding a transaction by a person discharging managerial responsibilities (PDMR) under MAR Regulation Article 19 has been received, and the full content is attached ('Pełną treści zawiadomienia załączono do niniejszego raportu.'). This structure—a brief announcement stating that the detailed report/notification is attached—fits the definition of a Report Publication Announcement (RPA) or, given the regulatory nature (MAR), potentially a general Regulatory Filing (RNS). Since the content describes an insider transaction notification (Director's Dealing), the most specific category is DIRS. However, the document itself is an announcement *about* the filing, not the filing content itself. Following Rule #2 (MENU VS MEAL), if the document is short and announces the availability of the full content, it should be RPA or RNS. Since this is a specific regulatory notification (MAR Art. 19), and DIRS is for the actual report of the dealing, RPA is the appropriate classification for the announcement of the filing's availability. Given the context of insider trading reports often being filed under specific local regulations that might not map perfectly to DIRS if the document is just the cover letter, RPA is the safest choice for a short announcement referencing an attached document.
2019-03-19 Polish
Rozszerzenie współpracy z Clairfield - Content (PL)
Capital/Financing Update Classification · 98% confidence The document discusses an amendment ('Aneks') to a previous agreement regarding transaction advisory services with Clairfield Partners LLC. The core purpose of this amendment is to support the company ('Scope Fluidics S.A.') in actions aimed at capitalizing ('dokapitalizowanie') the BacterOMIC project, specifically identifying potential investors for capital engagement and advising on the capital raising process. This clearly relates to fundraising, financing activities, and capital structure changes for a specific project. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document is a substantive update, not just an announcement of a report (ruling out RPA/RNS).
2019-03-12 Polish
Uszczegółowienie harmonogramu rozwoju systemu PCR|ONE i przyspieszenie prac nad systemem BacterOMIC - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement by Scope Fluidics S.A. (Emitent) updating stakeholders on the revised timelines and development schedules for two key projects: PCR|ONE and BacterOMIC. It details specific milestones, planned dates for certification, industrialization, and registration processes, and discusses financing and risk management related to these projects. This content—detailing strategic operational updates, project progress, and future plans—is characteristic of an Investor Presentation (IP) or a detailed Management Discussion and Analysis (MDA). Since it focuses heavily on the technical and strategic roadmap rather than just summarizing past financial results (ER) or providing a general overview (FS), Investor Presentation (IP) is the most fitting category, as these documents often contain detailed project roadmaps and technical updates for investors. It is not a regulatory filing like 10-K or IR, nor is it a short announcement of a report (RPA/RNS).
2019-03-07 Polish
Status projektu BacterOMIC - zakończenie trzeciego etapu prac nad projektem - Content (PL)
Regulatory Filings Classification · 92% confidence The document is a formal announcement from the Management Board (Zarząd) of Scope Fluidics regarding the completion of the third stage of research and development (R&D) for their BacterOMIC system. It details the successful validation of a prototype and pilot line, including specific technical achievements like developing algorithms for MIC determination and filing a patent. This type of detailed update on R&D progress, technological milestones, and business potential, especially when presented as a formal notification rather than a full financial report (like 10-K or IR), aligns best with an announcement concerning the company's ongoing projects and strategic development. Since there is no specific category for R&D progress, and it is not a standard financial report, earnings release, or management discussion, it is most appropriately classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the R&D progress directly impacts future funding needs, but RNS is the safer general category for specific operational/project updates that aren't explicitly covered elsewhere. Given the content is a detailed update on a core product development milestone, RNS (Regulatory Filings - general regulatory announcements) is the most suitable fallback.
2019-01-29 Polish
Powołanie Komitetu Doradczego - Content (PL)
Board/Management Information Classification · 98% confidence The document text announces the appointment of an Advisory Committee (Komitet Doradczy) on December 18, 2018, to support the Management Board (Zarząd) in the company's development and transfer of know-how. It lists the members appointed to this committee, detailing their expertise in diagnostics, microbiology, and biotech startup development. This announcement concerns the structure and advisory personnel related to the company's management and strategic direction, which aligns directly with the definition of Board/Management Information (MANG). The document is short and focuses entirely on this personnel/advisory structure change.
2018-12-18 Polish
Zakończenie prewalidacji systemu PCR|ONE w laboratoriach firmy ALAB - Content (PL)
Regulatory Filings Classification · 90% confidence The document is a formal announcement in Polish by the management board ('Zarząd Scope Fluidics') detailing the completion of a pre-validation phase for a diagnostic system (PCR|ONE) conducted by an independent laboratory (ALAB laboratoria). It reports on technical performance metrics (sensitivity, specificity) and outlines the next steps (optimization phase before pilot production). This type of communication, focusing on operational milestones, technical results, and future development plans, is characteristic of an update on ongoing business activities or a specific project milestone, rather than a standard financial report (10-K, IR, ER) or a general regulatory filing (RNS). Since it is a detailed update on a significant operational/development project, it fits best under 'Regulatory Filings' (RNS) as a general corporate announcement, as there is no specific category for R&D milestone updates, and it is not a management discussion (MDA) which usually accompanies financial results. Given the nature of the announcement (operational progress update), RNS is the most appropriate fallback.
2018-12-12 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.